Christos Andriopoulos, managing director of Merck, speaks about his experience transitioning from global operations to leading a country subsidiary. Andriopoulos goes on to explain the company’s unique positioning as an innovative specialty pharma player balancing a core business with an increasing focus on specialty areas. He also offers insights on the changing Belgian landscape in the context of political uncertainty but also future opportunities for continued partnership and innovation.
Merck is well-positioned to be a partner to the authorities in many ways including R&D, production, and technology integration
